专业监测看板

Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis

药物 / 成分：IV Ganciclovir、Normal saline

登记的停止原因（原文）：due to increased mortality and futility analyses

MBG453 in Lower Risk MDS

药物 / 成分：MBG453

登记的停止原因（原文）：The trial closed early due to changes in support for the study drug.

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes

药物 / 成分：AlloRx

登记的停止原因（原文）：Inadequate treatment response observed in preliminary data did not justify enrolling further study participants

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis

药物 / 成分：AlloRx

登记的停止原因（原文）：Inadequate treatment response observed in preliminary data did not justify enrolling further study participants

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF

药物 / 成分：AlloRx

登记的停止原因（原文）：Inadequate treatment response observed in preliminary data did not justify enrolling further study participants

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CKD

药物 / 成分：AlloRx

登记的停止原因（原文）：Inadequate treatment response observed in preliminary data did not justify enrolling further study participants

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease

药物 / 成分：AlloRx

登记的停止原因（原文）：Inadequate treatment response observed in preliminary data did not justify enrolling further study participants

Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis

药物 / 成分：AlloRx

登记的停止原因（原文）：Inadequate treatment response observed in preliminary data did not justify enrolling further study participants

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

药物 / 成分：INCB099280

登记的停止原因（原文）：This was a strategic business decision. There were no safety concerns contributing to this decision.

A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma

药物 / 成分：INCB099280

登记的停止原因（原文）：This was a strategic business decision. There were no safety concerns contributing to this decision.

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

药物 / 成分：GDC-6988

登记的停止原因（原文）：Sponsor's Decision

Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm

药物 / 成分：CSII in the prediction model group、CSII in the empirical group

登记的停止原因（原文）：Recruitment was stopped early because hospital length-of-stay constraints limited protocol delivery. The PI's decision also took account of the available non-inferiority results.

Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers

药物 / 成分：Supportive Care、Quality-of-Life Assessment、Questionnaire Administration

登记的停止原因（原文）：Feasibility issues

Evaluation of Structural and Functional Integrity of the Rotator Cuff After Total Shoulder Arthroplasty

药物 / 成分：CT scan of the shoulders

登记的停止原因（原文）：low enrollment

Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE

药物 / 成分：Collaborative care、Interview or Focus Group、Media/technology Intervention with collaborative care、Survey Administration

登记的停止原因（原文）：Study closed to accrual before meeting accrual goal due to enrollment challenges and end of funding.

Pulsed Lavage in Implant-Based Breast Reconstruction

药物 / 成分：Pulsed Lavage Washout、Implant-based breast reconstruction、Bilateral or unilateral mastectomy、Tissue expander

登记的停止原因（原文）：Changes in personnel

Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

药物 / 成分：Fluid biopsy capsule、Levodopa-Carbidopa Immediate Release

登记的停止原因（原文）：Study recruitment phase exceeded the time allotted

Retrospective Observational Study of Implant-supported Restorations With Dental Implants.

药物 / 成分：Dental Implants installed in an grafted area (sinus lifting)、Dental Implants installed in an grafted area (ridge augmentation)、Dental Implants installed in an grafted area (extraction sites)

登记的停止原因（原文）：The study was not terminated because we changed the methodology of the patient recruitment

Baroloop Multicenter Trial (Baroloop MCT)

药物 / 成分：baroloop system

登记的停止原因（原文）：Terminated following a device deficiency in 1 subject. Benefit-risk and development assessments did not support continuation within the planned framework. Root cause analysis pending.

Residual Gastric Content and GLP-1

登记的停止原因（原文）：The study was Terminated by primary investigator